The mechanisms by which FTO rs9939609 and rs17817449 polymorphisms contribute to MetS likely involve epigenetic regulation of metabolic genes and disruption of energy homeostasis, mirroring findings from related obesity-associated FTO variants. The gene discussed is FTO; the disease is obesity due to melanocortin 4 receptor deficiency.